Matusik RJ - Search Results

1

Greenberg NM, DeMayo F, Finegold MJ, Medina D, Tilley WD, Aspinall JO, Cunha GR, Donjacour AA, Matusik RJ, Rosen JM. Greenberg NM, et al. Among authors: matusik rj. Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3439-43. doi: 10.1073/pnas.92.8.3439. Proc Natl Acad Sci U S A. 1995. PMID: 7724580 Free PMC article.

2

Prolactin-mediated transcriptional and post-transcriptional control of casein gene expression.

Guyette WA, Matusik RJ, Rosen JM. Guyette WA, et al. Among authors: matusik rj. Cell. 1979 Aug;17(4):1013-23. doi: 10.1016/0092-8674(79)90340-4. Cell. 1979. PMID: 487427

3

Prolactin induction of casein mRNA in organ culture. A model system for studying peptide hormone regulation of gene expression.

Matusik RJ, Rosen JM. Matusik RJ, et al. J Biol Chem. 1978 Apr 10;253(7):2343-7. J Biol Chem. 1978. PMID: 632273 Free article.

4

Prolactin regulation of casein gene expression: possible mediators.

Matusik RJ, Rosen JM. Matusik RJ, et al. Endocrinology. 1980 Jan;106(1):252-9. doi: 10.1210/endo-106-1-252. Endocrinology. 1980. PMID: 6243098 No abstract available.

5

Multihormonal regulation of casein gene expression at the transcriptional and posttransciptional levels in the mammary gland.

Rosen JM, Matusik RJ, Richards DA, Gupta P, Rodgers JR. Rosen JM, et al. Among authors: matusik rj. Recent Prog Horm Res. 1980;36:157-93. doi: 10.1016/b978-0-12-571136-4.50011-5. Recent Prog Horm Res. 1980. PMID: 6997941 Review. No abstract available.

6

Large fragment of the probasin promoter targets high levels of transgene expression to the prostate of transgenic mice.

Yan Y, Sheppard PC, Kasper S, Lin L, Hoare S, Kapoor A, Dodd JG, Duckworth ML, Matusik RJ. Yan Y, et al. Among authors: matusik rj. Prostate. 1997 Jul 1;32(2):129-39. doi: 10.1002/(sici)1097-0045(19970701)32:2<129::aid-pros8>3.0.co;2-h. Prostate. 1997. PMID: 9215401

7

Workgroup 3: transgenic and reconstitution models of prostate cancer.

Green JE, Greenberg NM, Ashendel CL, Barrett JC, Boone C, Getzenberg RH, Henkin J, Matusik R, Janus TJ, Scher HI. Green JE, et al. Prostate. 1998 Jun 15;36(1):59-63. doi: 10.1002/(sici)1097-0045(19980615)36:1<59::aid-pros11>3.0.co;2-h. Prostate. 1998. PMID: 9650918 No abstract available.

8

Mutations at the boundary of the hinge and ligand binding domain of the androgen receptor confer increased transactivation function.

Buchanan G, Yang M, Harris JM, Nahm HS, Han G, Moore N, Bentel JM, Matusik RJ, Horsfall DJ, Marshall VR, Greenberg NM, Tilley WD. Buchanan G, et al. Among authors: matusik rj. Mol Endocrinol. 2001 Jan;15(1):46-56. doi: 10.1210/mend.15.1.0581. Mol Endocrinol. 2001. PMID: 11145738

9

Use of the probasin promoter ARR2PB to express Bax in androgen receptor-positive prostate cancer cells.

Andriani F, Nan B, Yu J, Li X, Weigel NL, McPhaul MJ, Kasper S, Kagawa S, Fang B, Matusik RJ, Denner L, Marcelli M. Andriani F, et al. Among authors: matusik rj. J Natl Cancer Inst. 2001 Sep 5;93(17):1314-24. doi: 10.1093/jnci/93.17.1314. J Natl Cancer Inst. 2001. PMID: 11535706

10

Adenovirus-mediated tissue-targeted expression of a caspase-9-based artificial death switch for the treatment of prostate cancer.

Xie X, Zhao X, Liu Y, Zhang J, Matusik RJ, Slawin KM, Spencer DM. Xie X, et al. Among authors: matusik rj. Cancer Res. 2001 Sep 15;61(18):6795-804. Cancer Res. 2001. PMID: 11559553

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters